ClinVar Miner

Submissions for variant NM_000314.7(PTEN):c.802-2A>T (rs587782455)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen PTEN Variant Curation Expert Panel RCV000710295 SCV000840462 pathogenic PTEN hamartoma tumor syndrome 2017-10-18 reviewed by expert panel curation PTEN c.802-2A>T (IVS7-2A>T) meets criteria to be classified as pathogenic for PTEN Hamartoma Tumor syndrome in an autosomal dominant manner using modified ACMG criteria (Mester et al. 2018; manuscript in preparation). Please see a summary of the rules and criteria codes in the 'PTEN ACMG Specifications Summary' document (assertion method column). PVS1: Null variant predicted to result in nonsense-mediated decay or causing truncation/frameshift at or 5' to c.1121 (NM_000314.4). PM2: Absent in large sequenced populations (PMID 27535533). PS4_P: Proband(s) with phenotype specificity score of 1-1.5. (Internal laboratory contributor(s), SCV000222230.9)
Ambry Genetics RCV000131528 SCV000186522 pathogenic Hereditary cancer-predisposing syndrome 2019-11-04 criteria provided, single submitter clinical testing Alterations at the canonical donor/acceptor sites (+/- 1, 2) without other strong (b-level) evidence supporting pathogenicity;In silico models in agreement (deleterious) and/or completely conserved position in appropriate species;RNA Studies;Detected in individual satisfying established diagnostic critera for classic disease without a clear mutation
GeneDx RCV000212884 SCV000222230 pathogenic not provided 2014-02-28 criteria provided, single submitter clinical testing The c.802-2 A>T destroys the canonical splice acceptor site in intron 7, and is expected to cause abnormal gene splicing. Although this mutation has not been reported previously to our knowledge, its presence is consistent with the diagnosis of a PTEN-related disorder. This mutation destroys the canonical splice acceptor site in intron 7, and is expected to cause abnormal gene splicing. The variant is found in PTEN-HEREDIC panel(s).
Cancer Genomic Medicine Translational Research Lab,Cleveland Clinic Genomic Medicine Institute RCV000516134 SCV000579242 pathogenic Cowden syndrome 1 2017-05-26 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.